Skip to content

Ap. Pharmamax

Active Private limited company (pre-2019)founded 1988active for 38 yearsPeter Benoitstraat 46, 2850 BoomKBO/BCE: BE 0434.458.941 subsidiary of

Lifetime

26 annual accounts with figures on one time axis, 39 filings since 1988
peak of €368,428 in 2023
€184,049▼ 47.9%
lowest -€156,530 in 2013
€130,718▼ 55.0%
peak of €377,746 in 2025
€377,746▲ 7.9%
€707,463▲ 7.2%
peak of 3 FTE in 2013
0 FTE▼ 100%
Board1 name since 2015
1 director
Owners2 names in the annual accounts
  
Documentsfilings and deeds
29-09-202660 days late
2025abbreviated format
Gross margin from €353,399 to €184,049Result from €290,195 to €130,718Staff from 0.8 FTE to 0 FTECash from €355,528 to €549,619

Key points

from the 2025 annual accounts

Equity

€377,746 ▲ 7.9%

Ap. Pharmamax has made a profit without a break since 2015.

Result

€130,718 ▼ 55.0%
€290,0002024€131,0002025

The result fell in 2025 from €290,195 to €130,718.

Filings

38 annual accounts 39 filings since 1988
AprilJune31 JulyOctober1990200020102020

Seven of the last ten came late. The 2022 accounts came in latest, 140 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,155 companies had the same profile as Ap. Pharmamax has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,155 companies, not a prediction for Ap. Pharmamax. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager, , since 01-09-2015
  • 100%score equity €1.3m (2025) · annual accounts 2021 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0434458941
Company renamed from Apotheek Vogelaers to Ap. Pharmamax (statutory manager) and (statutory manager) resign · appointed as sole manager · acts as permanent representative · Gazette deed
appointed as statutory manager General meeting of 20-11-2013 · Gazette deed
Resignations & appointments Gazette deed
All 54 events

Comparable companies

same main activity, similar in size and age
Company
Ap. Pharmamax Boom €1.1m €184,049 34.8% 0
FAMARO Tongeren-Borgloon €1.2m €190,250 89.3% 0
APOTHEEK RAUW Mol €1.1m €185,584 54.9% 0
APOTHEEK ANN JANSSENS Antwerp €1.0m €192,284 85.1% 0
Apotheek Popelier Bruges €0.8m €170,908 66.5% 0
APOTHEEK BEELE-LAMOTE Wevelgem €1.4m €212,256 57.2% 0.2
APOTHEEK MEES HAACHT CENTRUM Haacht €0.8m €196,602 29.3% 0

These companies have the same main activity as Ap. Pharmamax: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €767,000 and €1.4m, founded between 1977 and 2000.

Official details

Source: KBO
Status
Active since 04-06-1988Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.039.096.2872850 Boom, since 08-07-1988
Financial year end
31 December
Peppol
Reachable since 03-09-2025
Company details

Annual accounts 2025

≈ €860,000estimated
€1.1m▲ 7.4%
Filing
Filed on 29-09-2026
Financials

Insights on Ap. Pharmamax

Ap. Pharmamax files the abbreviated format. That format states no turnover. The gross margin rose from €151,022 in 2001 to €184,049 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Ap. Pharmamax

What is the company number of Ap. Pharmamax?
The company number of Ap. Pharmamax is 0434.458.941. The VAT number is the same number with BE in front: BE 0434.458.941.
Where is Ap. Pharmamax based?
The registered office is at Peter Benoitstraat 46, 2850 Boom.Company details
What does Ap. Pharmamax do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Ap. Pharmamax?
Ap. Pharmamax is a private limited company (pre-2019) (BVBA).
When was Ap. Pharmamax founded?
Ap. Pharmamax was founded on 04-06-1988.
Is Ap. Pharmamax still active?
Yes, Ap. Pharmamax is an active enterprise in the KBO register.
How many employees does Ap. Pharmamax have?
Ap. Pharmamax had an average of 0.8 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of Ap. Pharmamax?
The turnover in financial year 2025 is about €860,000. This figure is estimated from the gross margin of €184,049 and 43 comparable companies (NACE 477). It probably lies between €570,000 and €1.8m.
Is Ap. Pharmamax profitable?
In financial year 2025, Ap. Pharmamax made a profit of €130,718.
Where can I find the annual accounts of Ap. Pharmamax?
Ap. Pharmamax filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Ap. Pharmamax due?
Ap. Pharmamax must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.